izpis_h1_title_alt

Redox active or thiol reactive? : optimization of rapid screens to identify less evident nuisance compounds
ID Proj, Matic (Author), ID Knez, Damijan (Author), ID Sosič, Izidor (Author), ID Gobec, Stanislav (Author)

.pdfPDF - Presentation file, Download (1,04 MB)
MD5: 337A6DD3A8F2FD886FBFFDB28A3C2878
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S1359644622001167 This link opens in a new window

Abstract
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action.

Language:English
Keywords:redox, covalent, screening, hits, PAINS, assays
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:Str. 1733-1742
Numbering:Vol. 27, no. 6
PID:20.500.12556/RUL-139090 This link opens in a new window
UDC:615.4:54
ISSN on article:1359-6446
DOI:10.1016/j.drudis.2022.03.008 This link opens in a new window
COBISS.SI-ID:100881923 This link opens in a new window
Publication date in RUL:30.08.2022
Views:593
Downloads:109
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Drug discovery today
Shortened title:Drug discov. today
Publisher:Elsevier
ISSN:1359-6446
COBISS.SI-ID:1216021 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:redoks, kovalentni presejalni pregled, testi, farmacevtska kemija, zdravila

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back